About Vastu Vihar Biotech
Vastu Vihar Biotech is a Healthcare company based in Patna (India) founded in 2014. Drug development and research for autoimmune diseases in India. The company has 13 employees. Its Indian entity Vastu Vihar Biotech Private Limited reported revenue of ₹5.96 Cr. Vastu Vihar Biotech offers products and services including exRNA Therapies and Ribozyme-based Drugs. Its focus areas include Biotechnology, Drug Development, Autoimmune Disease Research and Research and Development.
Company details
Vastu Vihar Biotech is identified as an emerging company that focuses on drug development for autoimmune diseases, with research centered in Bodhgaya, Bihar. Techniques such as Extracellular RNA based therapies are employed to explore cures for conditions like Asthma, Psoriasis, and Chronic Hepatitis. The company operates laboratories equipped with advanced tools for biotechnological experiments, including sites in Bangalore, Hyderabad, and Varanasi. Efforts are directed towards pre-clinical and clinical trials to benefit patients and healthcare providers, ensuring progress in therapeutic solutions.
- Headquarters Patna, India
- Employees 13
- SectorsHealthcare
- Email••••••••
- Website vvbiotech.com
- Social LinkedIn X Facebook
- Legal Name Vastu Vihar Biotech Private Limited
- Date of Incorporation 28 Feb, 2014
- Jurisdiction Patna, Bihar, India
- Annual Revenue₹5.96 Cr
FY 2025 · +21% YoY
- Net Profit₹6.3 Lakh
FY 2025 · 1% margin
- EBITDA₹45.5 Lakh
FY 2025 · 8% margin
- Employee Count13
Associated legal entities of Vastu Vihar Biotech
Vastu Vihar Biotech operates through Vastu Vihar Biotech Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Vastu Vihar Biotech Private Limited CIN U51101BR2014PTC022119 | Active | 28 Feb 2014 | Patna, Bihar | ₹6.0 Cr | 13 | 3 | View details |
Products & Services of Vastu Vihar Biotech
Vastu Vihar Biotech offers a comprehensive portfolio of products and services, including exRNA Therapies and Ribozyme-based Drugs.
exRNA therapies for autoimmune diseases are developed to accelerate novel therapeutic solutions.
Ribozyme-based drugs for conditions like Asthma and Psoriasis are researched and prepared for pre-clinical trials.
Board of directors of Vastu Vihar Biotech Private Limited (Vastu Vihar Biotech)
Vastu Vihar Biotech Private Limited is the primary company behind Vastu Vihar Biotech. The board of Vastu Vihar Biotech Private Limited currently have 3 directors; the longest-serving is Vinay Kumar Tiwary, appointed in 2014.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Vinay Kumar Tiwary DIN 01000354 | Director | 28 Feb 2014 | 12 yrs 8 mo | Vastu Vihar Biotech Private Limited |
| Sushma Kumari DIN 01000269 | Director | 28 Feb 2014 | 12 yrs 8 mo | Vastu Vihar Biotech Private Limited |
| Satyam DIN 08042585 | Additional Director | 01 Aug 2018 | 8 yrs 3 mo | Vastu Vihar Biotech Private Limited |
People of Vastu Vihar Biotech
1 people are tracked at Vastu Vihar Biotech (1 in leadership); the tracked headcount is 13.
| Name | Role | Group |
|---|---|---|
Satyam Tiwary | CEO | Leadership |
Complete people profiles for Vastu Vihar Biotech
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Vastu Vihar Biotech
Figures of Vastu Vihar Biotech Private Limited, the primary company behind Vastu Vihar Biotech, for FY 2025. Revenue was ₹5.96 Cr (+21% year on year). Net profit was ₹6.3 Lakh (1% margin). EBITDA was ₹45.5 Lakh (8% margin). Revenue has grown at a compounded annual rate of +34% over three years and +33% over five years.
- ₹5.96 CrRevenue · FY 2025 · +21% YoY
- ₹6.3 LakhNet profit · 1% margin
- ₹45.5 LakhEBITDA · 8% margin
- ₹4.3 LakhPaid-up capital
- 13Employees (provident fund records)
- +34%Revenue CAGR, 3 years
- +33%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Vastu Vihar Biotech Private Limited are on its company page.
Detailed financial statements for Vastu Vihar Biotech
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Vastu Vihar Biotech
Vastu Vihar Biotech was founded in 2014.
Vastu Vihar Biotech is headquartered in Patna, India. It is registered at Patna, Bihar, India.
Vastu Vihar Biotech has 13 employees.
The primary company behind Vastu Vihar Biotech, Vastu Vihar Biotech Private Limited, reported revenue of ₹5.96 Cr for FY 2025, up 21% year on year.
Vastu Vihar Biotech is identified as an emerging company that focuses on drug development for autoimmune diseases, with research centered in Bodhgaya, Bihar. Techniques such as Extracellular RNA based therapies are employed to explore cures for conditions like Asthma, Psoriasis, and Chronic Hepatitis. The company operates laboratories equipped with advanced tools for biotechnological experiments, including sites in Bangalore, Hyderabad, and Varanasi. Efforts are directed towards pre-clinical and clinical trials to benefit patients and healthcare providers, ensuring progress in therapeutic solutions.
Vastu Vihar Biotech offers exRNA Therapies and Ribozyme-based Drugs.
Vastu Vihar Biotech operates through Vastu Vihar Biotech Private Limited.
The legal entities of Vastu Vihar Biotech currently have 3 directors, including Vinay Kumar Tiwary, Satyam, Sushma Kumari.